These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 25529394)

  • 1. First-line combination therapy with rituximab and corticosteroids provides a high complete remission rate in moderate-to-severe bullous pemphigoid.
    Cho YT; Chu CY; Wang LF
    Br J Dermatol; 2015 Jul; 173(1):302-4. PubMed ID: 25529394
    [No Abstract]   [Full Text] [Related]  

  • 2. Coexistence of psoriasis and bullous pemphigoid: remission with low-dose methotrexate.
    Gunay U; Gunduz K; Ermertcan AT; Kandiloğlu AR
    Cutan Ocul Toxicol; 2013 Jun; 32(2):168-9. PubMed ID: 22429144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type XVII collagen ELISA indices significantly decreased after bullous pemphigoid remission.
    Kusajima E; Akiyama M; Sato M; Natsuga K; Shimizu H
    Int J Dermatol; 2011 Feb; 50(2):238-40. PubMed ID: 21244398
    [No Abstract]   [Full Text] [Related]  

  • 4. [Bullous Pemphigoid Successfully Treated with Rituximab].
    Silva N; Costa A; Salvador F; Serradeiro E
    Acta Med Port; 2017 Mar; 30(3):243-246. PubMed ID: 28550834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of rituximab in a case of refractory bullous pemphigoid].
    Reguiaï Z; Tchen T; Perceau G; Bernard P
    Ann Dermatol Venereol; 2009 May; 136(5):431-4. PubMed ID: 19442800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case of atypical bullous pemphigoid with generalized pruritus and eczema as the prodrome for 10 years.
    Ikeda T; Okamoto K; Furukawa F
    J Dermatol; 2012 Aug; 39(8):720-1. PubMed ID: 22011062
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical Effectiveness and Safety of Initial Combination Therapy with Corticosteroids and Rituximab in Bullous Pemphigoid: A Retrospective Cohort Study.
    Tsai YJ; Cho YT; Chu CY
    Am J Clin Dermatol; 2022 Jul; 23(4):571-585. PubMed ID: 35579853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of adherence to topical corticosteroids in patients with bullous pemphigoid.
    Sobocinski V; Duvert-Lehembre S; Bubenheim M; Lesage C; Bernard P; Bénichou J; Joly P
    Br J Dermatol; 2016 Apr; 174(4):919-21. PubMed ID: 26556709
    [No Abstract]   [Full Text] [Related]  

  • 9. Remission Time after Rituximab Treatment for Autoimmune Bullous Disease: A Proposed Update Definition.
    Iranzo P; Pigem R; Giavedoni P; Alsina-Gibert M
    Skin Pharmacol Physiol; 2015; 28(5):255-6. PubMed ID: 26021780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of recalcitrant bullous pemphigoid (BP) with a novel protocol: A retrospective study with a 6-year follow-up.
    Ahmed AR; Shetty S; Kaveri S; Spigelman ZS
    J Am Acad Dermatol; 2016 Apr; 74(4):700-8.e3. PubMed ID: 26851830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bullous pemphigoid masquerading as recurrent vesicular hand eczema.
    Veien NK
    Acta Derm Venereol; 2010; 90(1):4-5. PubMed ID: 20107717
    [No Abstract]   [Full Text] [Related]  

  • 12. Dyshidrosiform palmoplantar pemphigoid in a young man: response to dapsone.
    Lupi F; Masini C; Ruffelli M; Puddu P; Cianchini G
    Acta Derm Venereol; 2010; 90(1):80-1. PubMed ID: 20107732
    [No Abstract]   [Full Text] [Related]  

  • 13. Evidence-based management of bullous pemphigoid.
    Daniel BS; Borradori L; Hall RP; Murrell DF
    Dermatol Clin; 2011 Oct; 29(4):613-20. PubMed ID: 21925006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective analysis of patients with bullous pemphigoid treated with methotrexate.
    Kjellman P; Eriksson H; Berg P
    Arch Dermatol; 2008 May; 144(5):612-6. PubMed ID: 18490587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A retrospective review of the therapeutic response with remission in patients with newly diagnosed bullous pemphigoid.
    Chuah SY; Tan SH; Chua SH; Tang MB; Lim YL; Neoh CY; Tan AW
    Australas J Dermatol; 2014 May; 55(2):149-51. PubMed ID: 24720427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bullous pemphigoid: a case series with emphasis on long-term remission off therapy.
    Kwatra SG; Jorizzo JL
    J Dermatolog Treat; 2013 Oct; 24(5):327-31. PubMed ID: 22268701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of bullous pemphigoid with low-dose methotrexate].
    Böhm I; Bauer R
    Hautarzt; 1997 Dec; 48(12):910-4. PubMed ID: 9486363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of concurrent pemphigoid vegetans and pemphigus vegetans resolving without oral corticosteroid.
    Hatano Y; Ishikawa K; Koga H; Ishii N; Hashimoto T; Takeo N; Shimada H; Sakai T; Okamoto O; Fujiwara S
    Br J Dermatol; 2014 May; 170(5):1192-4. PubMed ID: 24359309
    [No Abstract]   [Full Text] [Related]  

  • 19. [Bullous pemphigoid, primary biliary cirrhosis and vitiligo: a multiple autoimmune syndrome?].
    Marcet B; Sibaud V; Géniaux M; Taieb A
    Ann Med Interne (Paris); 2002 Sep; 153(5):349-50. PubMed ID: 12442082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical effect of omalizumab as an adjuvant treatment to rituximab in patient with refractory bullous pemphigoid.
    Kwon IJ; Kim T; Yoo DS; Min S; Kim SC; Kim JH
    J Dermatol; 2023 May; 50(5):705-709. PubMed ID: 36514846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.